RCAG
AGN

Rehmann Capital Advisory Group’s Allergan plc AGN Stock Holding History

Rehmann Capital Advisory Group’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$31.6K Sell
188
-20
-10% -$3.26K ﹤0.01% 755
2019
Q2 		$34.8K Buy
208
+44
+27% +$6.09K ﹤0.01% 963
2019
Q1 		$24K Buy
164
+33
+25% +$4.78K ﹤0.01% 1071
2018
Q4 		$17.5K Sell
131
-948
-88% -$155K ﹤0.01% 894
2018
Q3 		$206K Buy
1,079
+888
+465% +$163K 0.03% 392
2018
Q2 		$31.8K Sell
191
-274
-59% -$44K ﹤0.01% 937
2018
Q1 		$78K Buy
+465
New +$78K 0.01% 617
2017
Q3 		– Sell
-1,659
Closed -$403K – 403
2017
Q2 		$403K Sell
1,659
-121
-7% -$28.4K 0.08% 201
2017
Q1 		$425K Buy
1,780
+237
+15% +$55.2K 0.07% 211
2016
Q4 		$324K Sell
1,543
-343
-18% -$71.1K 0.06% 253
2016
Q3 		$434K Sell
1,886
-349
-16% -$85.3K 0.08% 198
2016
Q2 		$516K Buy
2,235
+144
+7% +$33.2K 0.1% 170
2016
Q1 		$560K Buy
2,091
+167
+9% +$47.8K 0.11% 156
2015
Q4 		$601K Buy
1,924
+353
+22% +$105K 0.13% 135
2015
Q3 		$427K Sell
1,571
-86
-5% -$26.4K 0.1% 161
2015
Q2 		$503K Buy
1,657
+280
+20% +$83.5K 0.11% 154
2015
Q1 		$410K Buy
+1,377
New +$393K 0.09% 181

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Rehmann Capital Advisory Group's AGN Position: Q3 2019 in Review

Rehmann Capital Advisory Group reduced its Allergan plc (AGN) stake by 9.6% in Q3 2019, selling an estimated $3.26K and leaving 188 shares worth $31.6K. The position accounts for ﹤0.01% of the portfolio, ranked #755.

Rehmann Capital Advisory Group first reported a position in AGN in Q1 2015 and has held it in 17 quarters since. The position peaked at $601K in Q4 2015. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

  • Rehmann Capital Advisory Group held 188 shares of Allergan plc worth $31.6K as of Q3 2019.
  • Rehmann Capital Advisory Group sold 20 Allergan plc shares in Q3 2019, an estimated $3.26K.
  • Allergan plc made up ﹤0.01% of Rehmann Capital Advisory Group's portfolio in Q3 2019, its #755 holding.
  • Rehmann Capital Advisory Group first reported a position in Allergan plc in Q1 2015 and has held it in 17 quarters since.
  • Rehmann Capital Advisory Group's Allergan plc position peaked at $601K in Q4 2015.
  • 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on Rehmann Capital Advisory Group's 13F filing for Q3 2019, filed 2 Jan 2020.